Market Cap: $969.53M
HC
Hanmi Financial Corporation
HAFC
NASDAQ (NASDAQ Global Select)USD
Market Cap: $969.53M
### Hanmi Financial Prepares for Critical Earnings Announcement Hanmi Financial, a leading player in the banking sector, is poised to release its quarterly earnings report on October 21, 2025. This an…
Hanmi Pharm Partners with Gilead Sciences to Revolutionize Oral Drug Delivery On September 29, 2025, Hanmi Pharm announces a strategic global licensing agreement with Gilead Sciences, Inc. and Health…
Hanmi Bank Partners with Koxa Corp to Revolutionize Digital Banking for Businesses In a significant move to enhance digital banking solutions for commercial clients, Hanmi Bank announces a strategic p…
Hanmi Financial Prepares for Key Earnings Announcement Amidst Economic Challenges Hanmi Financial Corporation is set to release its quarterly earnings report on July 22, 2025, a much-anticipated event…
Hanmi Pharmaceutical Expands Its Reach with Aditams Launch in Mexico Hanmi Pharmaceutical marks a pivotal moment in its international strategy with the launch of its urological product, Aditams, in Me…
Hanmi Pharmaceutical Expands Innovative Urological Treatments in Mexico Hanmi Pharmaceutical has officially launched its pioneering urological product, Aditams, in Mexico, marking a significant advanc…
Hanmi Pharmaceutical Expands Its Footprint in North America with Innovative Dispensing Technology Hanmi Pharmaceutical, headquartered in Seoul, South Korea, is making significant strides in the North…
Korea Zinc's Governance Struggle: A Clash Over Shareholder Rights Korea Zinc is currently embroiled in a significant governance dispute as its board proposes resolutions aimed at enhancing shareholder…
Innovative Obesity Treatment Unveiled by Hanmi Pharm at ObesityWeek 2024 Hanmi Pharm. Co., Ltd. makes significant strides in obesity treatment with the introduction of HM17321 during ObesityWeek 2024,…
Hanmi Pharm. Breaks Ground in Obesity Treatment with HM17321 Hanmi Pharm. Co., Ltd. makes significant strides in obesity management with the introduction of its innovative drug, HM17321, during the 20…
Hanmi Pharm’s Breakthrough in Obesity Treatment: HM17321 Hanmi Pharm. Co., Ltd. makes waves in the obesity treatment landscape with the recent unveiling of HM17321 at the 2024 ObesityWeek conference i…